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The prognosis of patients who are admitted in a comatose state following successful resuscitation after cardiac
arrest remains uncertain. Although the introduction of therapeutic hypothermia (TH) and improvements in post-
resuscitation care have significantly increased the number of patients who are discharged home with minimal brain
damage, short-term assessment of neurological outcome remains a challenge. The need for early and accurate
prognostic predictors is crucial, especially since sedation and TH may alter the neurological examination and delay
the recovery of motor response for several days. The development of additional tools, including electrophysiological
examinations (electroencephalography and somatosensory evoked potentials), neuroimaging and chemical biomarkers,
may help to evaluate the extent of brain injury in these patients. Given the extensive literature existing on this
topic and the confounding effects of TH on the strength of these tools in outcome prognostication after cardiac
arrest, the aim of this narrative review is to provide a practical approach to post-anoxic brain injury when TH is
used. We also discuss when and how these tools could be combined with the neurological examination in a
multimodal approach to improve outcome prediction in this population.Review
Clinical scenario
A 52-year old woman collapsed on the street and under-
went bystander cardiopulmonary resuscitation. Emergency
medical personnel arrived 8 minutes later and found the
patient in asystole; cardiopulmonary resuscitation was con-
tinued and return of spontaneous circulation was finally
obtained 23 minutes after arrest, after a total of 4 mg intra-
venous epinephrine. The initial electrocardiogram sug-
gested an inferior ST-elevation myocardial infarction. The
patient was transferred to the emergency department and
underwent emergency coronary angiography, which re-
vealed a proximal right coronary artery occlusion, even-
tually treated by percutaneous stenting. At 90 minutes post
arrest, the patient arrived in the ICU, hemodynamically
stable but comatose, with bilateral flexor responses to pain-
ful stimuli and absent pupillary reflexes; she was not re-
ceiving sedative agents. Therapeutic hypothermia (TH)
was immediately initiated. When the patient’s relatives
arrived, they immediately asked about the extent of* Correspondence: ftaccone@ulb.ac.be
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© 2014 BioMed Central Ltd.brain damage and chances for survival and neurological
recovery.Hypoxic–ischemic encephalopathy: the problem
Cardiac arrest (CA) is a devastating event associated
with mortality rates in excess of 90% [1]. Among pa-
tients who achieve return of spontaneous circulation,
more than 40% survive to ICU admission and nearly
30% are discharged alive from the hospital. The most
important reason for poor outcome remains the post-
cardiac arrest syndrome, a pathophysiological process
characterized by three main components: brain injury,
myocardial dysfunction, and systemic ischemia/reperfusion
response [2]. The severity of these disorders is not uniform
and may depend on the cause, the duration of the CA
and the extension of the ischemic injury; however, brain
injury remains the most common cause of death in
these patients [3,4].How to predict neurological outcomes in hypoxic–ischemic
encephalopathy
Prognostication in hypoxic–ischemic encephalopathy (HIE)
is a particular challenge because decisions to withdraw
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prognosis [4]. A systematic review highlighted how the
neurological examination (absent pupillary light response
or corneal reflexes, absent or posturing motor responses
to pain, myoclonus status epilepticus), high serum
neuron-specific enolase (NSE) and bilateral absence of
cortical somatosensory evoked potentials (SSEPs) could
reliably predict poor outcome in comatose survivors after
CA [5]. Nevertheless, such an approach has been ques-
tioned recently; specifically, introduction of TH as a
neuroprotective intervention after return of sponta-
neous circulation [6] may significantly influence the
neurological examination and also potentially modify
the prognostic value of circulating biomarkers of
brain damage or the accuracy of SSEPs [7-9].
The aim of this review is to provide a practical
approach to the comatose patient surviving after anoxic
injury and treated with TH, and to outline when and how
the available tools should be combined with the neuro-
logical examination in a multimodal approach to improve
the quality of prognostic assessment (Figure 1).Clinical examination
Clinical manifestations after CA depend on the suscepti-
bility of different brain regions to anoxia (for example,
the cerebral cortex, thalamus and cerebellum are more
susceptible than subcortical areas and the brainstem).
After reperfusion, brainstem functions, including spon-
taneous breathing and reflexes, return more rapidly thanFigure 1 Multimodal approach to assess prognosis in comatose survi
approach to assess prognosis in comatose survivors after cardiac arrest trea
combined with the use of electroencephalography (EEG) and somatosenso
specific enolase (NSE) and S-100β protein) and magnetic resonance imaginthose related to deep brain structures (for example,
response to pain).
In patients not treated with TH, a lack of motor re-
sponse or extensor response to pain (Glasgow Coma
Score – Motor Response (GCS-M) ≤2), bilateral lack of
pupillary reflexes and bilateral lack of corneal reflexes at
72 hours after CA have all been regarded as reliable
signs of a poor prognosis [10]. Today, however, the cli-
nical course of neurological recovery is obscured by se-
dation and muscle paralysis associated with TH during
the first 24 to 48 hours post arrest, a period during
which most survivors without significant brain injury
might recover responsiveness. In addition, hypothermia
may prolong the metabolism of sedative agents and in-
duce drug accumulation, with significant impact on the
timing of neurological recovery [11]. As such, early as-
sessment of a poor prognosis based only on the clinical
examination may contribute to withdrawal of life-
sustaining therapy in nearly 20% of patients who may
otherwise have shown complete neurological recovery
[12]. Use of sedatives could negatively influence the pre-
dictive value of clinical examination within the first 72
hours after TH initiation [13,14]. The amount of se-
dation used probably varies considerably between cen-
ters, and this may explain why the clinical examination
has been reported as reliable in some studies and less
reliable in others.
During the initial period after CA, when cooling and
concomitant sedation is used, the only reliable prognos-
tic information is limited to a minority of patients whovors after cardiac arrest treated with hypothermia. The multimodal
ted with hypothermia should ideally include neurological examination
ry evoked potentials (SSEPs), the measurement of biomarkers (neuron-
g (MRI).
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stem functions as signs of total brain infarction and/or
herniation [4]. The detection of asymmetrical motor re-
sponse or stretch reflexes should indicate the need for a
neuro-radiological investigation to detect focal brain in-
jury; however, use of neuromuscular blockers with TH
may limit these clinical signs to being present only on
admission. Great care should be taken to avoid a prema-
ture diagnosis of brain death because recovery of brain-
stem function may occur even in more severe cases [15].
In clinical practice, additional tools – including electro-
encephalography (EEG) and neuroimaging – should be
used to confirm extensive brain injury and swelling.
When sedation is weaned during rewarming, recovery
of at least a localizing motor response to pain (GCS-M
≥5) is a sign of a favorable prognosis [16] and no further
diagnostic tests are necessary if the patient continues to
improve over subsequent days. On the other hand, if the
patient remains unresponsive to pain or with only a
stereotypic motor response (GCS-M <4), the prognosis
worsens each day without sedation and complementary
prognostic tests have to be considered. Indeed, GCS-M
≤2 alone on day 3 was associated with a false positive
rate (FPR; that is, the proportion of patients misclassified
when this variable is used) for poor outcome of 12 to
24% [17,18], whereas the combination of such abnorma-
lities with myoclonus or absent brainstem reflexes (that
is, pupillary and corneal reflexes) reduced the FPR to
<4% [17]. Pupillary and corneal reflexes should be tested
daily in all patients, because their absence has been asso-
ciated with poor prognosis in several studies [18-20].
However, few data are available about changes in these
reflexes over time and the reactivity of constricted pupils
or reaction to corneal stimulation may be difficult to
assess reliably and can also be altered by deep se-
dation. Finally, the optimal timing to define prognosis
using the neurological examination remains unknown.
One could propose the need to delay prognosis assess-
ment until 72 hours after normothermia has been
achieved (that is, 4 to 5 days after CA), but no reliable
data are available on the reliability and predictive value
of clinical tests at this timepoint [14].
Clinical seizures are reported in about one-quarter of
CA victims [21,22], but various forms of motor manifes-
tations are often misinterpreted as seizures [23]. Myoclo-
nus is a common event following CA that may or may
not be an epileptic manifestation [24]. Occasional myo-
clonic jerks have little prognostic value in patients suf-
fering from HIE. In a recent study, post-hypoxic
myoclonus was reported in 20% of patients, 9% of whom
had a good outcome [24]. Generalized (including face
and limbs) myoclonus is often associated with burst sup-
pression on EEG and is an ominous sign, especially if it
occurs within the first 24 hours and persists for morethan 30 minutes (that is, status myoclonus) [25]. Before
the introduction of TH, status myoclonus was consi-
dered a reliable sign of poor prognosis if it occurred
following a primary CA [5], whereas good outcome
was occasionally reported if the arrest was of hypoxic
origin [26]. Since myoclonus usually occurs early and
is usually suppressed by sedatives, status myoclonus is
less frequently observed in hypothermia-treated CA
survivors and cannot constitute by itself a sign of poor
outcome [27].
Electroencephalography
The use of EEG is advocated to detect seizures and post-
anoxic status epilepticus, which occur in 10 to 40% of
patients and are associated with a poorer outcome
[19,21,22], particularly when detected early during TH
[28]. Nevertheless, good neurological outcome has been
reported following aggressive anti-epileptic therapy for
seizures occurring in the rewarming phase [29], espe-
cially in selected patients (that is, those with preserved
brainstem reflexes, present cortical response on SSEPs
and a reactive EEG).
In addition to seizure detection, EEG has been used to
identify specific patterns associated with outcome during
HIE (Figure 2). A dichotomized definition of EEG pat-
terns, such as malignant or benign, has been developed.
EEGs are considered to have a malignant pattern if post-
anoxic status epilepticus, alpha coma or burst suppres-
sion or generalized suppression is present. Other EEG
patterns, including a generalized slowing activity, gener-
alized alpha–theta frequencies or the presence of epilep-
tiform discharges, are considered benign or of unclear
significance. In CA patients not treated with TH, 84% of
survivors had benign patterns whereas 88% of nonsurvi-
vors had malignant patterns [30]. In a recent study, 12%
of survivors and 86% of nonsurvivors after CA had a
malignant EEG pattern within the first 3 days [19]; inter-
estingly, a malignant EEG pattern was associated with a
0% FPR to discriminate patients with good and poor
outcome in those treated with TH in this study. How-
ever, benign EEG patterns could not distinguish patients
with neurological recovery in another study [31]. These
data suggest that a malignant pattern could be used to
predict extensive brain injury after CA, regardless of
the use of TH; however, other benign findings or fin-
dings of unclear significance are not predictive of
neurological recovery.
Dynamic changes in the EEG (that is, cerebral reacti-
vity) are dependent on the integrity of the ascending re-
ticular activating system and are strongly associated with
arousal [32]. A nonreactive EEG, defined as the absence
of any reproducible change in amplitude or frequency
upon patient stimulation, was significantly associated
with in-hospital mortality after CA [17,19]. EEG
Figure 2 Electroencephalogram findings from resuscitated patients after cardiac arrest. (A) Electroencephalogram (EEG) recorded during
therapeutic hypothermia, showing an example of continuous EEG: the patient had complete recovery of consciousness. (B) Burst-suppression
findings during normothermia; the patient had concomitant myoclonus and bilateral absent N20 cortical responses to somatosensory evoked
potentials, and eventually died. (C) Generalized periodic epileptiform discharges at 36 hours after hospital admission; we decided to withdraw
care on day 5 because of persistent coma with posturing and absent pupillary reflexes.
Taccone et al. Critical Care 2014, 18:202 Page 4 of 12
http://ccforum.com/content/18/1/202reactivity also had a better predictive value for neuro-
logical outcome than malignant/benign EEG patterns
and predicted awakening in patients with an EEG pat-
tern of alpha-coma after CA [33,34]. Nevertheless,
standard EEG in these studies was performed only at
the end of treatment, under normothermic conditions.
In patients treated with TH monitored with continuous
EEG, a nonreactive EEG was strongly associated with a
poor outcome [17,19], with an even better predictivevalue than SSEPs [28]. On the other hand, a reactive
EEG is often associated with a good recovery [28].
Moreover, the presence of a continuous EEG pattern
(as opposed to an EEG showing flat periods and/or
spontaneous burst-suppression patterns) early during TH
was associated with a high probability of recovery
[35,36]. Thus, when an EEG is performed in comatose
survivors after CA, both the EEG pattern and reactivity
should be recorded to assess the extent of brain injury.
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ting. First, lack of a universally accepted classification for
different EEG patterns can lead to differences in defini-
tions. As such, post-anoxic paroxysms – classified as
periodic electrographic discharges by some neurologists
– could be considered as post-anoxic status epilepticus
by others. Recently, a simplified classification with four
major EEG patterns after CA was proposed: flat pattern,
continuous pattern, suppression-burst pattern, and elec-
trographic status epilepticus [35,37]. This approach pro-
vided valuable prognostic information, could be easily
interpreted even by non-neurologists and may facilitate
data comparison among studies; however, these findings
need to be validated in a larger patient cohort.
Second, the diagnosis of absent/present EEG reactivity
relies on the experience and expertise of the neurologist
who interprets the EEG. The exact stimulus needed to
reproduce EEG changes and reactivity has not been
clearly standardized. Moreover, muscle activity after
weaning from sedation may produce artifacts and neces-
sitate muscle relaxation. Reactivity can thus be easily
tested only during TH, but few data are available on the
time course of EEG reactivity after CA.
Finally, continuous EEG may enable a better evalu-
ation of brain function over time; however, a recent
statement recommended continuous EEG over intermit-
tent EEG only for seizure detection in patients withFigure 3 Somatosensory evoked potentials. (A) In comatose survivors a
transcutaneous electrical stimulation applied to the median nerve and then
controlateral cortex (N20). (B) Example of present N20 cortical response (C3
N20 cortical response (C3’) in two comatose patients after cardiac arrest.refractory status epilepticus, whereas both techniques
are effective at improving prognostication in post-anoxic
coma [38].Somatosensory evoked potentials
The SSEP is a small (<10 to 50 μV) electrical signal that
can be recorded non-invasively from the skull after ad-
ministering a set of electrical stimuli to one of the per-
ipheral nerves. In CA patients, the median nerve is most
commonly stimulated bilaterally at the wrist. Electrodes
are then placed at the elbow, Erb’s point, the cervical
medulla (peripheral) and on the parietal and frontal cor-
tex (cortical); specific responses are commonly identified
as N9 for Erb’s point, N14 for the cervical medulla and
N20 for cortex [39]. The cortical responses can only be
reliably interpreted when the peripheral and spinal re-
sponses are also present (Figure 3). If peripheral re-
sponses are not present, this may be due to peripheral
nerve damage. For prognosis of a poor outcome after
CA, only the short cortical latencies (N20, expected to
appear 20 milliseconds after median nerve stimulation)
are used. In order to have absent SSEPs, predictive of a
poor outcome, cortical responses have to be absent bila-
terally in a technically well-performed test [40]. In pa-
tients who remain comatose after CA, SSEPs have
been shown to reliably predict poor outcome [5,14].fter cardiac arrest, somatosensory evoked potentials are elicited by
recorded at Erb’s point (N9), the cervical medulla (N13) and the
’) in two comatose patients after cardiac arrest. (C) Example of absent
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rate sedation or metabolic disturbances and remain
present even at a sedation level that is sufficient to in-
duce an isoelectric EEG [39]. Propofol produces min-
imal to <10% suppression of the SSEP amplitude [41].
Midazolam and opioids also have only a moderate ef-
fect on SSEP amplitude and latency. Remifentanil can
suppress the cortical SSEP components by 20 to 80%
when given at high doses (0.8 μg/kg/minute), as used
during neuromonitoring in the operating room [42].
A systematic review of studies on CA patients before
TH implementation showed that bilateral absence of
N20 on day 1 or day 3 after CA could certainly predict
poor neurological outcome. Some false positives were
identified when SSEPs were performed too early (within
1 day) after the anoxic injury; thus, this test should not
be performed earlier than 24 hours after arrest [43]. In
two large prospective studies performed in patients treated
with TH, the bilateral absence of N20 at rewarming
(that is, on day 2 or day 3) was a reliable tool to pre-
dict poor outcome, with a FPR of 0% [17,18], and a
pooled analysis of recent studies [14,17,18,44,45] still
gave a very low FPR of <0.5%. Unfortunately, only a
small proportion of patients with a poor outcome
after resuscitation have absent SSEPs, resulting in a
low sensitivity [46]. Moreover, preservation of the N20
response does not imply a favorable outcome; indeed,
almost one-half of the patients with a present N20 will
have a poor outcome.
A limitation of SSEP is that it has only moderate inter-
pretation reproducibility. In one study, SSEP recordings
from 56 patients with HIE were interpreted indepen-
dently by five experienced clinical neurophysiologists.
The inter-observer agreement was moderate (kappa 0.52,
95% confidence interval = 0.20 to 0.65) with the main
source of disagreement related to noise levels [47], which
should therefore be reduced as much as possible – for
example, by giving muscle relaxants to patients with too
much muscular activity. Electrical ICU equipment that
can interfere with readings should also be turned off
whenever possible. Providing more stimuli (up to 1,000
or more) and increasing the stimulus intensity can also
improve the signal-to-noise ratio [47].
Biomarkers
Biomarkers are quantifiable biological substances, usu-
ally peptides, which can be easily measured in peripheral
blood. Biomarkers of brain injury in comatose survivors
from CA include NSE and S-100β [48,49].
Before widespread use of TH, serum NSE levels
>33 μg/l at 72 hours after CA were strongly associated
with poor prognosis [40,50]; the reported FPR varied
from 0 to 3% [5]. However, Tiainen and colleagues
showed that hypothermia may significantly reduceserum NSE levels, probably by selective attenuation of
neuronal injury [8]. The cutoff values for NSE predictive
of a poor outcome were also significantly higher in pa-
tients treated with TH than in those without cooling
[51]. Finally, a single high NSE measurement on day 3
after CA and TH remained associated with a poor out-
come but with a FPR ranging from 7 to 29% [18,19], and
much higher NSE cutoff values (>50 to 80 μg/l) would
be necessary to predict poor outcome without false posi-
tives [52,53].
High concentrations of S-100β have also been found
in patients remaining comatose after CA; however, dif-
ferent cutoff levels, ranging from 0.2 to 1.5 mg/l, have
been proposed to predict poor neurological outcome in
this setting [54,55]. Before widespread use of TH, S-
100β levels within the first 2 days after hospital admis-
sion could predict outcome in comatose patients with
HIE with a FPR of 2 to 5% [5]. More recent studies have
compared the predictive values of NSE and S-100β after
TH, yielding conflicting results [8,40]. Although S-100β
has a very short half-life and could potentially be more
sensitive for detecting extensive brain damage within the
first 24 hours of hypoxic injury, most of the existing data
relate to NSE, which remains the most commonly used
biomarker in this setting. Furthermore, NSE levels have
been shown to have a strong correlation to several other
prognostic indicators after CA, including EEG changes
[56,57].
Importantly, both biomarkers have important pitfalls;
because NSE is found in red blood cells and platelets
levels may increase in cases of hemolysis or NSE-
producing masses, whereas S-100β can be released from
adipocytes and chondrocytes, and levels may thus in-
crease as a result of chest compressions [58]. Variability
in handling of blood samples, including storage, centri-
fugation and freezing procedures, are other potential
causes of error [59]. Disadvantages also include the lack
of standardized assays, which may explain the differ-
ences in reported cutoff levels reported in the literature
[60]. Finally, if CA occurs concomitantly with other
brain diseases, such as stroke or traumatic brain injury,
the contribution of HIE to elevated biomarker levels
may be difficult to distinguish.
Imaging
Current guidelines state that available data are insuffi-
cient to support the use of computed tomography (CT)
imaging in neuro-prognostication of comatose CA survi-
vors [61]. Nevertheless, early CT could be helpful to rule
out a cerebral cause of coma and/or CA, especially in
cases with preceding neurological symptoms, in cases
with nonshockable rhythms or in young patients without
cardiovascular risk factors [62,63]. Moreover, as brain
death may occur in up to 10% of patients in the days
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neurological catastrophe in patients being considered for
brain death determination.
Some studies have evaluated the predictive value of
CT for predicting neurological outcome after CA. A loss
of distinction between gray and white matter, indicating
cerebral edema, has been associated with a lower likeli-
hood of good outcome [64-66]. Other studies have sug-
gested that a ratio of Hounsfield units in the gray matter
versus the white matter <1.18 can accurately predict
poor outcome [67,68]. However, these studies are limited
by the small numbers of patients. The largest study to
date, including 151 patients, illustrated the utility of CT
imaging by incorporating whole brain Hounsfield units;
a decrease in this value, especially in combination with
traditional clinical features, was highly specific for pre-
dicting poor outcome while maintaining acceptable sen-
sitivity [69].
Magnetic resonance imaging (MRI) provides a more
sensitive indication of brain injury after CA compared
with CT, and the use of apparent diffusion coefficient
values has recently helped to quantify the degree of in-
jury (Figure 4) [70-72]. Apparent diffusion coefficient
maps are used to create diffusion-weighted images
(DWI), a technique that relies on the concept of re-
stricted diffusivity of water across dysfunctional cell
membranes, such as those of ischemic neurons. Cyto-
toxic edema occurs secondary to failure of ion pumps,
leading to increased intracellular water content as ionsFigure 4 Diffusion-weighted magnetic resonance imaging. Diffusion-w
suffered a ventricular fibrillation cardiac arrest with prolonged resuscitation
global anoxic injury.are no longer adequately pumped out of ischemic neu-
rons. Fluid-attenuated inversion recovery (FLAIR) se-
quences are T2-weighted, but with suppression of the
cerebrospinal fluid signal, allowing for high sensitivity
but relatively weak specificity for lesions. FLAIR is
particularly sensitive to vasogenic edema.
Regional (that is, the occipital and temporal lobes),
spatial (that is, widespread and diffuse lesions) or tem-
poral (that is, absence of resolution in FLAIR abnormal-
ities) MRI findings may provide better insight into the
degree and mechanisms of hypoxic–ischemic brain in-
jury, and hence better predict outcome in comatose sur-
vivors, including those treated with TH [73-75]. Bilateral
hippocampal hyperintense signals on DWI and FLAIR
also appear to be specific imaging indicators of poor
prognosis in patients who suffer global hypoxic–ische-
mic injury [76]. The ideal timing to perform MRI would
be 2 to 5 days after CA (or after TH, if performed); du-
ring this time, DWI abnormalities in combination with
the neurological examination on day 3 improved the
sensitivity for predicting poor outcome by 38%, while
maintaining 100% specificity [70]. However, one should
emphasize that most studies of neuroimaging for CA pa-
tients are limited by their retrospective nature, heteroge-
neous populations (for example, not all patients were
comatose), and the self-fulfilling prophecy of early with-
drawal of life-sustaining therapy (that is, the falsely
pessimistic interpretation of prognostic variables con-
currently used to forgo life support) [77]. Additionally,eighted magnetic resonance imaging scan of a 68-year-old man who
. Diffuse cortical hyperintensities are observed, consistent with severe
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certain than that of poor outcome, and both CT and MRI
need to be further evaluated in well-conducted prospec-
tive studies in the CA population.
Multimodal prognostic algorithm
Previous studies have suggested some benefits of a
multimodal approach. Before the implementation of TH,
the addition of NSE measurements to the Glasgow
Coma Scale and SSEP increased the predictability of
poor neurological outcome from 64% to 76% [78]. Com-
bination of the neurological examination, EEG findings,
SSEPs and two serum biomarkers improved prognostic
value with no false positives for death [79]. In patients
treated with TH, the use of SSEPs, NSE and EEG in-
creased the number of patients identified as having a
poor outcome from 75% to 88% [52]. Also, the combin-
ation of arrest duration, Glasgow Coma Score and non-
contrast brain CT findings on admission was a strong
predictor of mortality with severe neurological disability,
showing a 100% specificity and positive predictive value
[67]; however, the quite small cohort population and the
absence of clear recommendation for withdrawal of care
are major confounders for this study.
Importantly, the precise multimodal approach will vary
among centers depending on the availability of electro-
physiological monitoring, technical expertise and laboratoryFigure 5 Multimodal prognostication of coma after cardiac arrest and
cardiac arrest of all available tools that are used to predict poor outcome o
prognosis or neurological recovery should be considered when specific fin
of care should be initiated, because this approach has not been validated.
biomarker levels did not relate to a specific cutoff value because of several
burst suppression; BSR, brainstem reflexes; EEG, electroencephalogram; GPE
response or posturing; MRI, magnetic resonance imaging; N20, cortical resp
lase; SM, status myoclonus; SSEP, somatosensory evoked potential; uNCSE,facilities, and the use of several prognostic tools does
increase costs. Also, self-fulfilling prophecy should be
avoided and considerable efforts have to be addressed
to combine the different variables to accurately pre-
dict neurological outcome. Finally, decisions to with-
draw life support should also require good education
and training, should require good communication be-
tween the ICU team, and should be based on the ethical
principles of autonomy, beneficence, nonmaleficence
and justice.
Taking into account all of the previous referenced
studies, we thus propose a combination of several prog-
nostic tools to improve the accuracy of predicting good
and poor outcomes after HIE and TH (Figure 5). After
initial neurological examination (at hospital admission
and before sedation and muscular paralysis to induce
TH, whenever possible), continuous or repeated stand-
ard EEG monitoring should be started already during
TH to identify the presence of early seizures, of malig-
nant EEG patterns and of EEG reactivity. Evidence of re-
active EEG or continuous background activity indicates
a high probability of good neurological recovery, and
these patients usually wake up rapidly after rewarming
and discontinuation of sedation. In contrast, malignant
patterns – including burst suppression, generalized peri-
odic epileptiform discharges and cerebral inactivity (that
is, a flat EEG or unreactive background) – are associatedtherapeutic hypothermia. Summary of the suggested timing after
r neurological recovery from coma. This algorithm suggests that poor
dings are present but this does not necessarily mean that withdrawal
Dashed lines, lack of strong evidence to support the suggestion. High
limitations affecting their measurements and accuracy (see text). BS,
D, generalized periodic epileptiform discharge; M1–2, absent motor
onses to somatosensory evoked potentials; NSE, neuron-specific eno-
unreactive nonconvulsive seizures; uSE, unreactive status epilepticus.
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therapy should be considered for post-anoxic status epi-
lepticus, especially if it occurs in the rewarming phase in
the absence of other signs of extensive brain injury; in
contrast, early nonconvulsive seizures are often associ-
ated with a poor outcome, especially if associated with
an unreactive EEG and nonresponse to anti-epileptic
treatment. The effect of treatment on this kind of
seizures is uncertain.
Importantly, no EEG finding should be used alone to
predict poor outcome, and these negative EEG patterns
need to be correlated with neurological examination at
48 to 72 hours after the end of TH, when sedation has
been withheld for at least 24 hours. If patients have gen-
eralized persistent status myoclonus during the first 24
hours, poor outcome can be predicted if it is associated
with bilateral absence of N20 after rewarming. If SSEPs
are not available, a malignant EEG pattern increases the
likelihood of poor prognosis but further diagnostic
work-up (including brain imaging and biomarkers)
should be considered. It is reasonable to assume a poor
neurological outcome in patients with absent pupillary/
corneal reflexes and GCS-M ≤2 on day 3 after CA. How-
ever, prognostic accuracy is increased if these signs are
associated with an unreactive EEG or malignant pat-
terns. In other comatose patients, bilateral absence of
N20 potentials 48 to 72 hours after CA indicates irre-
versible brain damage. If these findings (that is, malig-
nant EEG, poor clinical findings and bilateral absence
of N20 potentials) are absent, prognostication be-
comes more difficult. The combination of high NSE
and S-100β levels with widespread DWI or FLAIR MRI
lesions should be considered as additional tools to iden-
tify extensive cerebral injury. Because these methods
have some limitations, they should not be used to make
final decisions on treatment levels. Rather, a prolonged
observation period (1 to 2 weeks) should be considered
to allow for delayed neurological recovery.
Perspectives and areas for future clinical investigation
Considering the limits of the neurological examination,
certain electrophysiological tests have been proposed. A
simplified EEG method with a limited number of EEG
electrodes, in combination with amplitude-integrated
EEG, could be used in comatose survivors of CA, and
may provide relevant and rapid bedside information that
could be evaluated also by non-neurologists [35,37].
Functional deficiency of the auditory–frontal cortex net-
work of auditory discrimination is a common finding
shared by different neurological disorders with cognitive
impairment [80]. This deficiency can be measured with
the so-called mismatch negativity, an EEG finding that is
elicited during a specific auditory stimulus using sounds
that differ in pitch, duration or loudness. Mismatchnegativity has been shown to better predict awakening
than SSEPs in patients remaining comatose several days
after CA [81]. In a study by Tzovara and colleagues, all
nonsurvivors showed deterioration in mismatch negati-
vity between two measurements, whereas all those pa-
tients who had an early improvement in auditory
discrimination regained consciousness [82]. Finally, long
latency evoked potentials, such as P70 and P300, have
been correlated with neurological status in CA survivors
after 3 and 6 months; however, these potentials are
difficult to perform in the early phase and do not pro-
vide additional predictive value to the available electro-
physiological tests [9,83].
Analysis of the time course of biomarkers could also
improve their predictive value. An increase in NSE levels
by >2 μg/l between 24 and 48 hours after CA was re-
ported as a strong predictor of poor outcome [48].
Preliminary studies have shown that other blood bio-
markers, including glial fibrillary acidic protein, neuro-
filaments or tau protein, may represent alternative
biomarkers [84-86]. Also, because the post-CA syndrome
activates a systemic inflammatory response syndrome
similar to that of sepsis [2], C-reactive protein, copeptin
and especially procalcitonin could be considered adjunc-
tive tools to assess prognosis [87-89]. The combination
of such molecules with biomarkers of heart injury, such
as cardiac troponins and brain natriuretic peptide, along
with novel biomarkers, including circulating cell-free
DNA and micro-RNAs, could create a multipanel of
biomarkers to incorporate into the prognostication
process of CA patients [58].
Advanced MRI techniques could provide interesting
information, although their usefulness is less clear than
conventional neuroimaging techniques. Some of the
newer techniques include diffusion tensor imaging, frac-
tional anisotropy, functional MRI (including resting-
state and task-specific functional MRI) using blood oxy-
gen level-dependent contrast, and high angular reso-
lution diffusion imaging tractography. These imaging
techniques can evaluate brain oxygenation, regional ac-
tivation in response to external stimuli, neuronal struc-
ture and axonal myelination, and all these findings
may give new insight into the investigation of post-
anoxic brain injury.
Conclusions
Accurate prognostication of comatose patients suffering
from HIE and treated with TH can be obtained only 72
to 96 hours after CA and requires a multimodal ap-
proach. The neurological examination remains the gold
standard; however, motor responses may be delayed up
to 5 days in patients undergoing TH and neurological
examination is not sufficient to accurately predict prog-
nosis. The addition of EEG could improve prognostic
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24 hours from CA) reactive EEG pattern as a finding
suggestive of good prognosis, whereas a nonreactive or
burst-suppressed EEG pattern is associated with a poor
outcome. Bilateral absence of N20 at 48 to 72 hours is
almost invariably associated with a poor prognosis.
Serum biomarkers of brain damage (NSE and S-100β)
may be useful to assess the severity of acute brain injury;
however, they should never be used alone and further
studies are needed to better define predictive cutoff
levels. Findings from MRI investigations could poten-
tially help to identify patients with extensive hypoxic–
ischemic brain injury. Additional tools are under investigation
to further improve the quality of prognosis assessment in
this population.
Key messages
 The clinical examination remains the gold standard
for assessing prognosis in comatose survivors after
CA; however, the use of sedatives and cooling
procedures severely limit the early use of clinical
findings in this setting.
 Previous guidelines should no longer be applied in
clinical practice to assess brain function in patients
treated with TH.
 There is no optimal timing to assess prognosis after
CA.
 We recommend the use of a multimodal approach,
including full neurological examination with at least
SSEPs and EEG, to help with coma prognostication
after CA and TH.
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